8 LITERATURVERZEICHNIS

Abbas, A.K, Lichtman A. H., Pober J.S. (1996): Immunologie, Verlag Hans Huber, Bern. Göttingen.Toronto. Seattle, 2: 80-83 und 77-85.

Adams, P., Fowler, R., Howell, G., Kinsella, N., Skipp, P., Coote, P., O`Connor, C.D. (1999): Defining protease specificity with proteomics: a protease with a dibasic amino acid recognition motif is regulated by a two-component signal transduction system in Salmonella. Electrophoresis 20: 2241-2247.

Anderson, N.L., Tracyrp, Anderson, N.G. (1984): High - resolution two - dimensional electrophoretic mapping of plasma proteins. In: The Plasma Proteins. Vol. IV. Plutnam FW, Hrsg. New York: Academie Press; 221-70.

Anderson, N.G. und Anderson, N.L. (1996): Twenty years of two-dimensional electrophoresis: past, present and future. Electrophoresis 17(3), 443-53.

Asaka, M., Kimura, T., Kato, M., Kudo, M., Miki, K., Ogoshi, K., Kato, T., Tatsuta, M., Graham, D.Y.,. Possible role of H. pylori infection in early gastric cancer development. Cancer. (1994); 73: 2691-2694.

Azuma,T., Kato,T., Hirai, M., Ito,S., Kohli,Y. (1996): Diagnosis of Helicobacter pylori infection. J. 11: 662-669.

Banerjee, S., Hawksby, C., Miller, S., Dahill, S., Beattie, A.D., McColl, K.E.L. (1994): Effect of Helicobacter pylori and its eradication on gastric juice ascorbic acid. Gut; 35: 317.

Bannister, J.V., Bannister, W.H., Rotilio, G. (1987): Aspects of the structure, function and application of superoxidase dismutase. CRC Crit. Rev. Biochem. 22: 111-180.

Bazzoli, F., Zagari, R.M., Fossi, S., Pozzato, P., Alampi, G., Simoni, P., Sottili, S., Roda, A., Roda, E. (1994): Short-term low-dose triple therapy for the eradication of Helicobacter pylori. Eur. J. Gastroenterol. Hepatol. 1994; 6: 773-777.

Berkowicz, J., Lee, A. (1987): Lancet 1987 / II: 680-681.

Bizzozero, G.: Über die schlauchförmigen Drüsen des Magendarmkanals und die Beziehung ihres Epithels zu dem Oberflächenepithel der Schleimhaut. Arch. Mikr. Anat. 42, 82-152 (1893).

Blaser, M.J. (1990): Helicobacter pylori and the pathogenesis of gastroduodenal inflammation. Journal of Infectiosus Diseases. 161: 626-633 .

Blaser, M.J. und Parsonnet, J. (1994): Parasitism by the "slow" bacterium Helicobacter pylori leads to altered gastric homeostatis and neoplasia. Journal of Clinical Investigation. 94: 4-8.

Blaser, M.J. (1997): Ecology of Helicobacter pylori in the human stomach. Journal of Clinical Investigation. 100: 759-762.

Blaser, M.J. (1992): Hypotheses on the pathogenesis and natural history of H. pylori-induced inflammation. Gastroenterol. 102: 720-727.

Blaser, M.J. (1993 ): Helicobacter pylori: microbiology of a "slow" bacterial infection. Trends in Microbiology 1: 255-260.

Blaser, M.J., Smith, P.F., Repine, J.E., Joiner, K.A. (1988): Pathogenesis of Campylobacter fetus infections. J. Clin. Invest. 81: 1434-1444.

Blecker, U., Lanciers, S., Hauser, B., Mehta, D.J., Vandenplas, Y. (1995): Serology as a valid screening test for Helicobacter pylori infection in asymtomatic subjects. Arch. Pathol. Lab. Med. 119 (1): 30-32.

Blum, A.L., Bayerdörffer, E., Börsch, G., Classen, M., Creutzfeldt, W., Hotz, J., Koob, J., Labenz, J., Malfertheiner, P., Rösch, W., Schepp, W., Stolte, M., Stremmel, W., Suerbaum, S. (1997): The Helicobacter revolution. Leber-Magen-Darm. 3: 170-177.

Blum, A.L., Kreiss, C., Armstrong, D. (1995): Funktionelle Dyspepsie: Ansätze für eine Helicobacter pylori-Eradikationstherapie. Leber-Magen-Darm 25 (3/95): 112-113.

Bock, H., Mares, A. (1997): Aktueller Stand der Helicobacter pylori - Eradikationstherapie. Fortschritte der Medizin 115 Jg.-Originalien Nr.II-III/1997, S.31-35.

Bohmeyer, J., Heller, A., Hartig, C. et al. ( 1996 ): Assoziation der chronischen Urtikaria mit Helicobacter- pylori-induzierter Antrum - Gastritis. Hautarzt 1996; 47: 106-108.

Börsch, G. (1988): Leber - Magen - Darm 18, 9-16.

Börsch, G., Mai, U., Rühl, G.H. (1989): Fortschritte der Medizin (Autorisierter Sonder-Druck); 1989 Urban und Vogel, München: 8.

Boettcher, A. (1874): Zur Genese des perforierenden Magengeschwürs. Dorbater Medizinische Zeitschrift, 5: 148.

Caspry, W.F. und Rösch, W. (1997): Diagnosis and treatment of helicobacter pylori infection-reply. Leber-Magen-Darm 27: 179-180.

Caspary, W.F. (1996): Leitlinie der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankheiten (DGVS) in Frankfurt vom Oktober 1995 bis April 1996 und Zeitschrift für Gastroenterologie 34: 392-401.

Cho, C., Murthy, U.K., Linscheer, G., Pèrez-Pèrez, G.I., Blaser, M.J. (1994): Is intestinal metaplasia a consequence of H. pylori gastritis? Gastroenterology 106 (4): A 62.

Christie, J.M., McNulty C.A., Shepherd, N.A., Valori, R.M. (1996): Is saliva serology useful for the diagnosis of Helicobacter pylori ? GUT 39: 27-30.

Clarkson, K.S., West, K.P. (1993): Gastric cancer and Helicobacter pylori infection. J. clin. Pathol. 46: 997-999.

Clayton, C.L., Pallen, M.J., Kleanthous, H., Wren, W., Tabaqchali, S. (1990): Nucleotide sequence of two Genes from Helicobacter pylori encoding for urease subunits. Nucl. Acids res. 18: 362.

O´Connor, C.D., Farris, M., Fowler, R., Qi, S.Y. (1997): The proteome of Salmonella enterica serovar typhimurium: current progress on ist determination and some applications. Electrophoresis 18: 1483-1490.

Correa, P., Ruiz, B. (1989): Campylobacter pylori and gastric cancer. In: Rathbone B.J., Heatley R.V., editors. Campylobacter pylori and gastroduodenal disease. Oxford: Blackwell; 139.

Covacci, A., S.Censini, M.Bugnoli, R.Petracca, D.Burroni, G.Macchia, A.Massone, E. Papini, Z.Xiang, N.Figura et al. (1993): Molecular characterization of the 128-KDa immunodominant antigen of Helicobacter pylori associated with cytotoxicitiy and duodenal ulcer. Proc. Natl. Acad. Sci. U.S.A. 90: 5791-5795.

Cover, L.T., Dooley, C.P., Blaser, M.J. (1990): Charakterization of and human serologic response to proteins in Helicobacter pylori broth culture supernatans with vacuolating cytotoxin activity. Infect. Immun. 58: 603-610 .

Crabtree, J.E., Peichl, P., Wyatt, J.I., Lindly, I.J.D. (1992): Gastric interleukin-8, and Anti-interleukin-8 IgA antibodies in Helicobacter pylori infection. Ir. J. Med. Sci. 161: 20.

Cutler, A.F., Prasad, V.M. (1996): Long-term follow-up of Helicobacter pylori serology after succesful eradication. Am. J. Gastroenterol. 91 (1): 85-88.

Denizot, Y., Sobhani, I., Rambaud, J-C., Lewin, M., Thomas, J., Benveniste, J. (1990): Paf-acether Synthesis by helicobacter pylori. Gut, 31: 1242-1245.

Dixon, M. (1993): Acid, ulcers, and H. pylori. Lancet 342: 384-85.

Dooley, C.P., Fitzgibbons, P., Cohen, H., Appleman, M.D., Perez-Perez, G., blaser, M.J. (1988): Prevalence and distribution of Campylobacter pylori in an asymptomatic population (abstract). Gastroenterology 94, A 102.

Dunn, B.E., Campell G.P., Perez-Perez, G.I., Blaser M.J. (1990): Purification and charakterization of Urease from H. pylori. J.Biol.Chem. 265: 29-34.

Dunn, B.E., Roop II, R.M., Sung, C.C., Sharma, S.A., Perez-Perez, G.I., Blaser, M.J. (1992): Identification and purification of a cpn60, heat shock protein homolog from H. pylori. Infect.Immun. 60: 1946-1951.

Dye, K.R., Marshall, B.J., Frierson Jr., H.F., Pambianco, D.J., McCallum, R.W. (1990): Campylobacter pylori colonizing heterotopie gastric tissue in the rectum. Am. J.Clin.Pathol. 93: 144-147.

Eck, M., Schmaußer, B., Haas, R., Greiner, A., Czub, S., Müller-Hermelink, H.K. (1997): MALT-type lymphoma of the stomach is associated with Helicobacter pylori strains expressing the Cag A protein. Gastroenterology; 112 . 1482-1486.

Eckerskorn, C., Mewes, W., Goretzki, H., Lottspeich, F. (1988): Eur. J. Biochem. 176: 509-519.

Eldrige, J., Lessels, H.M., Jones, D.M. (1984): Antibody to spiral organisms on gastric mucosa. Lancet 1, 1237.

Evans, D.J. Jr., Evans, D.G., Graham, D.Y. (1993): Identification of an iron-containing superoxidase dismutase in Helicobacter pylori. Acta Gastro-Enterologica Belgica 56 (Suppl.): 110.

Faulde, M., Schroder, J.P., Sobe, D. (1992): Serodiagnosis of Helicobacter pylori infection by detection of immunoglobulin G antibodies using an immunoblot technique and enzyme immunoassay. Eur J Clin Microbiol Infect 11: 589-594.

Faulde, M., Cremer, J., Zoller, L. (1993): humoral immuno response against Helicobacter pylori as determined by immunoblot. Electrophoresis 14: 945-951.

Fiocca, R., Luinetti, O., Villani, L., Chiaravalli, A., Cornaggia, M., Stella, G., Perego, M., Trespi, E., Solcia, E. (1993): High incidence of H. pylori colonization in early gastric cancer and the possible relationsship to carcinogenesis. Eur.J. Gastroenterol. Hepatol. 5: 2-8.

Fischbach, W. (1999): Gastrointestinale Lymphome.Deutsches Ärzteblatt 96, Heft 16: 37-40.

Forman, D., Newell D.G., Fullerton F., Yarnell YWG, Stacey A.R, Wald N., Sitas F. (1991): Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation; 1302-1305.

Forman, D. (1992): Helicobacter pylori infection and gastric carcinogenesis. Eur. J. Gastroenterol. 4 (2): 31-35.

Forman, D., Webb P. (1993): Geographic distribution and association with cancer. In: Northfield TC, Mendall M, Coggin PM, eds. Helicobacter pylori Infection. London: Kluwer Academic; 11-20.

Freedberg, A.S. and Barron, L.E. (1940): The presence of spirochetes in human gastric mucosa. Am. J. Dig. Dis. 7: 443-445.

Fukuda, H., Saito, D., Hayashi, S. (1995): Helicobacter pylori infection, serum pepsinogen level and gastric cancer: a case-control study in Japan. Jpn.J.Cancer Res. 86: 64-71.

Geesey, G.G. (1982): Microbial exopolymers: ecological and economic considerations. ASM News 48: 9-14.

Glick, G.R., Pasternak, J.J. (1994): Molekulare Biotechnologie, Spektrum Akad. Verlag, Heidelberg. Berlin. Oxford; 202.

Goodwin, C.S., Worsley, B.W. (1993): Microbiology of Helicobacter pylori. Gastroenterol. Clin. North Am.; 22 (1): 5-19.

Goodwin, C.S., Armstrong, J.A. (1990): Microbiological aspects of Helicobacter pylori. Eur. J. Clin. Microbiol. Infect. Dis. 9: 1-3.

Goodwin, C.S. (1988): Duodenal ulcer, Campylobacter pylori and the "leaking roof" Concept. Lancet; ii. 1467.

Goodwin, C.S., Armstrong, J.A., Marshall, B.J. (1986): Campylobacter pyloridis, gastritis and peptic ulceration. J. Clin. Pathol. 39, 353-365.

Gormally, S.M., Kierce, B.M., daly, L.E. (1996): Gastric metaplasia and duodenal ulcer disease in children infected by Helicobacter pylori. Gut 38: 513-17.

Graham, D.Y., Malaty, H.M., Evans, D.G., Evans, D.J.J., Klein, P.D., Adam, E. (1991a): Epidemology of Helicobacter pylori in an asymptomatic population in the United States. Effect of age, race, and socioeconomic status. Gastroenterology 100: 1495 - 1501.

Graham, D.Y., Adam, E., Reddy, G.T., Agarwal, J.P., Agarwal, R., Evans, D.J., Malaty, H.M., Evans, D.G. (1991b): Seroepidemology of Helicobacter pylori infection in India. Comparison of developing and developed countries. Dig. Dis. Sci. 36: 1084-1088.

Hazell, S.L., Evans, D.J., Graham, D.J. (1991): Helicobacter pylori catalase . J. Gen. Microbiol. 137: 57.

Heilmann, K.L., Stolte, M., Borchard, F., Heine, M., Löning, Th., Ottenjann, R., Remmele, W., Rühl, G., Schaefer, H.E., Schlake, W., Seib, H.J., Stamm, B., Steininger, H., Wiebecke, B. (1989): Gastritis - Graduierung und Klassifikation. Verh. Dtsch. Ges. Path. 73, 569-570.

Heukeshoven, J., Dernick, R. (1985): Simplifed method for silver staining of proteins in polacrylamid gels and the mecanism of silver staining. Elektrophoresis 6, 103-112.

House, C., Wettenhall, R.E., Kemp, B.E. (1987): The influence of basic residues on the substrate specificity of protein kinase. C.Journal Of Biological Chemistry. 262 (2), 772-7.

Huang, J.Q., Sridhar, S., Chen, Y. (1998): Meta-analysis of the relationship between Helicobacter pylori and gastric cancer. Gastroenterology 114: 1169-79..

Johansen, H.K., Norgaard, A., Andersen, L.P., Jensen, P., Nielsen, H., Hoiby, N. (1995): Cross-reactive antigens shared by Pseudomonas aeruginosa, Helicobacter pylori, campylobacter jejuni, and Haemophilus influenza may cause false-positive titers of antibody to H. pylori. Clin Diagn Lab Immunol 2: 149-155.

Jones, D.M., Eldridge, J., Whorwell, P.J. (1987): Brit. med. J. 294: 615.

Jungblut, P.R., Stöffler, G. (1997): Praktikum. Zweidimensionale Gelelektrophorese von Proteinen. Institut für mikrobiologie der Medizinischen Fakultät der Universität Innsbruck. 14-15.

Jungblut, P.R., Bumann, D., Haas G., Zimny-Arndt, U., Holland P., Lamer S., Siejak F., Aebischer A., Meyer T.F. (2000): Comparative proteome analysis of helicobacter pylori. Mol. Microbiol. 36: 710-25.

Jungblut, P.R., Grabher, G., Stöffler, G. (1999): Comprehensive detection of immuno-relevant Borrelia garinii antigens by two - dimensional elektrophoresis. Elektrophoresis 20: 3611-3622.

Kahn, P. (1995): From genome to proteome: looking at a cell's proteins (news). Science. 270 (5235). 369-70.

Kikuchi, S., Wada, O., Nakajima, T. (1995): Serum anti - Helicobacter pylori - antibody and gastric carcinoma among young adults. Cancer. 75; 2789-93.

Kimmel, B., Bosserhoff, A., Frank, R., Groß, R., Goebel, W., Beier, D. (2000): Identification of Immunodominant Antigens from Helicobacter pylori and Evaluation of Their Reactivities with Sera from Patients with Different Gastroduodenal Pathologies. Infection and Immunity, Feb.2000, p. 000-000; 138.

Kist, M. (1988): Zur Epidemiologie, Prävalenz, Histopathologie und klinischen Symptomatik der Campylobacter pylori - Besiedlung. In: Ottenjann, R., Schmitt, W. (eds.): Aktuelle Gastroenterologie - Campylobacter pylori. Springer Verlag, Berlin (1988), 66-74.

Klaamas, K., Held, M., Wadstrom, T., Lipping, A., Kurtenkov, O. (1996): IgG immune response to Helicobacter pylori antigens in patients with gastric cancer as defined by ELISA and immunoblotting. Int J Cancer 67: 1-5.

Klose, J. (1995): Protein mapping by compined isoelectric focusing and electrophoresis in mouse tissues. A novel approach to testing for induced point mutations in maamals. Humangenetik. 26, 123-243.

Kolts, B.E., Joseph, B., Achem, S.R., Bianchi, T., Monteiro, C. (1993): Helicobacter pylori. Detection A Quality and Analysis. Am. J. Gastroenterol., 88: 650-55.

Kolibasova, K., Cervencova, D., Hegyi, E., Lengyelova, J., Toth, J. (1994): Helicobacter pylori - Ein möglicher ätiologischer Faktor der chronischen Urtikaria. Dermatosen 1994; 42: 235-236.

Krajden, S., Fuksa, M., Anderson, J., Kempston, J., Boccia, A., Petrea, C., Babida, C., Karmali, M., Penner, J.L. (1989): Examination of human stomach biopsies, saliva, and dental plaque for Campylobacter pylori. J. Clin. Microbiol. 27: 1397-1398.

Kramer, M.D. (1997): Immunologie und Immunpathologie, Ferdinand Enke Verlag, Stuttgart; 142-151.

Krienitz, W. (1906): Über das Auftreten von Spirochäten verschiedener Formen im Mageninhalt bei Carcinoma ventriculi.. Dtsch.Med.Wochenschr 28: 872.

Labenz, J. und Börssch, G. (1996): Aktuelle Therapie der Helicobacter-pylori-Infektion in: Helicobacter pylori - Von der Grundlage zur Therapie: Malfertheiner, P. (1996). Georg-Thieme-Verlag. Stuttgart.New York. (2.Auflage) 149-160.

Lee, A., Hazell, S.L. (1988): Campylobacter pylori in health and disease: an ecological perspective. Microb. Ecol. Healtth. Dis. 1: 1-16.

Lehn, N., Megraud, F. (1996): Diagnosis of Helicobacter pylori. Curr. Opin. Gastroent. 12, 6-10.

Lehninger, E.L., Nelson, D.L., Cox, M.M. (1994): Prinzipien der Biochemie (2.Auflage), Spektrum Akademischer Verlag, Heidelberg. Berlin. Oxford: 151-160.

Levi, S., Beardshall, K., Haddad, G., Playford, R., Ghosh, P., Calam, J. (1989): Campylobacter pylori and duodenal ulcers: the gastrin link. Lancet; i: 1167.

Lindkvist, P., Asrat, D., Nilsson,I., Tsega, E., Olsson, G.L., Wretlind, B. und Giesecke, J. (1996): Age at acquisition of Helicobacter pylori infection - coparison of a high and a low prevalence country. Scandinaivan Journal of Infectiosus Diseases. 28: 181-184.

Lior, H., Johnson, W.H. (1985): Catalase, peroxide dismutase activities in Campylobacter spp. In: Pearson, A.D., Skirrow, M.B., Lior, H. and Rowe, B.(Eds.): Campylobacter III: Proceedings of the Third International Workshop on Campylobacter Infections. Public Health Laboratory Service, London, pp. 226-227.

Lodisch, H., Baltimore, D., Berk, A., Zibursky, S.L., Matsudaira, P., Darroll, J. (1996): Molekulare Zellbiologie, 2. Auflage, de Gruyter; Berlin. New York; 94-102.

Lohaus, C., Meyer, H.E. (1998): Proteomforschung in: Biospektrum. 5.98: 32-33.

McAtee, C.P., Lim, M.Y., Fung, K., Velligan, M., Fry, K., Chow, T., Berg, D.E. (1998): Identification of Potential Diagnostic and Vaccine Candidates of Helicobacter pylori by Two-Dimensional Gel Elektrophoresis, Sequence Analysis, and Serum Profiling. Clinical and Diagnostic Laboratory Immunology, July 1998, p.537-542; 99.

McNulty, C.A.M. (1989): Detection of Helicobacter. Pylori by the biopsy urease test. In: Rathbone, B.J.,Heatly, R.V. (Hrsg.): Campylobacter pylori and gastroduodenal disease. Oxford: Blackwell Scientific Publications: 69-73.

Malfertheiner, P.: Nicht-ulzeröse Dyspepsie - chronische Gastritis in: Malfertheiner, P. (Hrsg.): Campylobacter pylori - neuer Aspekt bei chronischer Gastritis und peptischem Ulkus.. Unas Verlag. Aachen 35-40.

Malfertheiner, P. (1996): Helicobacter pylori - Von der Grundlage zur Therapie. 2. Auflage. G. Thieme Verlag . Stuttgart. New York . 17.

Malfertheiner, P., Megraud, F., O'Morain, C., Bell, D., Bianchi, P.G., Deltentre, M., Forman, D., Gasbarrini, G., jaup, B., Misiewicz, J.J., Pajares, J., Quina, M., Rauws, E. (1997): Current European consepts in the management of Helicobacter pylori infection - the Maastricht Consensus Report. The European Helicobacter Pylori Study Group (EHPSG). European Journal of gastroenterology and Hepatology. 9: 1-2.

Marshall, B.J. and Warren, J.R. (1984): Unidentified curved bacilli in the stomach of patient with gastritis and peptic ulceration. The Lancet 16: 1311-1314.

Marshall, B., Arbstrong, J., McGechie, D., Glancy, R. (1985): Attempt to fulfil Koch`s postulate for pyloric Campylobacter. Med. J. Aust. 152: 436-439.

Marshall, B.J. (1986): Campylobacter pyloridis and gastritis. J. Infect. Dis. 153, 650-657.

Megraud, F. (1996): Advantages and disadvantages of current diagnostic tests for the detection of Helicobacter pylori. Scandinavian Journal of Gastroenterology. 31: 57-62.

Mitchell, H.M., Li, Y.Y., Hu, P.J., Liu, Q., Chen, M., Du, G.G., Wang, Z.J., Lee, A., Hazell, S.L. (1992a): Epidemology of Helicobacter pylori in Southern China - Identification of early childhood as the critical period for acquisition. J. Infect. Dis. 166: 149-153.

Mitchell, H.M., Li, J., Hu, P., Hazell, S.L., Du, G., Byrne, D.J., Lee, A. (1992b): The susceptibility of Helicobacter pylori to bile may be an obstacle to faecal transmission. Eur. J. Gastro. Hepatol. 4 (Suppl. 1): 79-83.

Mitchell, H.M. et al.: Lancet (1987 / II): 681-682.

Moayyedi, P., Feltbower, R., Brown, J., Mason, S., Mason, J., Nathan, J., Richards, G., Dowell, A.C., Axon, A.T.R. (2000): Effect of population screening and treatment for Helicobacter pylori on dyspepsia and quality of life in the community: a randomised controlled trial. THE LANCET. Vol 355. May 13, 2000: 1665-1667.

Morgner, A., Bayerdörffer, E., Malfertheiner, P. (1997): Therapeutischer Übersichtsplan Helicobacter pylori. Medizin im Bild 5/1997: 48-49.

Morris, G.P., Bass B.K., Holitzner C.A., Williamson, T. E. (1993): Mucosal secretion and cytoprotection of the rat gastric mucosa. J. Clin. Gastroenterol. 17 (Suppl.1): S.5 - S.10.

Newell, D.G,. Stacey, A. (1989): Antigens for die serodiagnosis of Campylobacter pylori infections. Gastroenterol. Clinique. Biolog., 13: 219 - 223.

Nilsson, I., Ljungh, A., Aleljung, P., Wadstrom, T. (1997): Immunoblot assay for serodiagnosis of Helicobacter pylori infections. J Clin Microbiol 35: 427-432.

Nishizono, A., Gotoh, T., Fujioka, T., Murakami, K., Kubota, T., Nasu, M., Watanabe, M., Mifune, K. (1998): Serological assessment of the early response to eradication therapy using an immunodominant outher membrane protein of Helicobacter pylori. Clin Diagn Lab Immunol 5: 856-861.

Nomura, A., Stemmermann, G.N., Chyou, P.H. et al. (1991): Helicobacter pylori infection and gastric carcinoma among japanese americans in Hawaii. N. Engl. J .Med. 325, 1132-1136.

Norgaard A., Nielsen, H., Andersen, L.P. (1993). Activation of human phagocytes by Helicobacter pylori - a novel interaction with neutrophiles and monocytes distict from that of N - formylated oligopeptides. Zbl. Bakt.- Int. J. Med. Microbiol. 280-86.

O'Brien, B., Goeree, R., Mohamed, A.H., Hunt, R. (1995): Cost-effectiveness of Helicobacter eradication for the long-term management of duodenal ulcer in Canada. Archives of Internal Medicine. 155: 1958-1964.

O’Connor, C.D., Farris, M., Fowler R., Qi, S.Y. (1997): The proteome of Salmonella enterica serovar typhimurium: current progress on ist determination and some applications. Electrophoresis. 19: 1483-90.

Parsonnet, J., Friedman G.D.,Vandersteen D., Chang, Y., Vogelman, J.H., Orentreich, N., Sibley, R.K.: Helicobacter pylori infection and the risk of gastric carcinoma. N. Engl., J.Med. (1991): 325: 1127-1131.

Parsonnet, J. (1993): Helicobacter pylori and gastric cancer. Gastroenterol. Clin. N. America; 22, 1: 89.

Parsonnet, J., Hansen, S., Rodriquez, L., Gelb, A.B., Warnke, R.A., Jellum, E., Orentreich, V., Vogelman, J.H., Friedman, G.D. (1994): Helicobacter pylori-infection and gastric lymphoma. N. Engl. J. Med. (1994); 330: 1267-1270.

Perez-Perez, G.I., Taylor, D.N., Bodhidatta, L., Wongsrichanalai, J., Baze, W.B., Dunn, B.E., Echeverria, P.D., Blaser, M.J. (1990): Seroprevalence of Helicobacter pylori infection in Thailand. J. Infect. Dis. 161: 1237-1241.

Perez-Perez, G.I., Dworkin, B., Chodos, J., Blaser, M.J. (1988): Campylobacter pylori antibodies in humans. Ann. Intern. Med. 109: 11-17.

Peura, D. (1998): Helicobacter pylori: rational management options. American Journal of Medicine. 105: 424-430.

Pounder, R.E., Ng, D. (1995): The prevalence of Helicobacter pylori infection in different Countries. Aliment Pharmacol. Ther. 9 (Suppl. 2): 33-39.

Price, A.B. (1991): The Sydney System: Histological division. Journal of Gastroenterology and Hepatology; 6: 209-22.

Price, A.B., Misiewicz, J.J. (1992): Grading in classification of chronic gastritis: the response of the working party. Gastroenterology 103. 1116.

Raedsch, R., Pohl, S., Plachky, J., Stiehl, A., Kommerell, B. (1989): The growth of Campylobacter pylori is inhibited by intragastric bile acids. In: Megraud, F., Lamouliatte, H. (eds.). Gastroduodenal pathology and campylobacter pylori. Elsevier. Amsterdam, pp. 409-412.

Rathbone, B.J., Wyatt,J.I., Heatly, R.V. (1986): Campylobacter pyloridis-a new factor in peptic ulcer disease ? Gut. 27: 635-641.

Rathbone, B.J., Wyatt, J.I., Worsley, B.W., Shires, S.E., Trejdosiewicz, L.K., Heatley, R.V., Losowsky, M.S. (1987): Systemic and local antibody responses to gastric Campylobacter pyloridis in non - ulcer dyspepsia. Gut. 642-647.

Rebora, A., Drago, F., Picciotto, A. (1994): Helicobacter pylori in patients with rosacea. Am. J. Gastroenterol. 89: 1603-1604.

Risch, G. (1998): Antikörpertypisierung. Institut Dr. Risch; Laboratorien FAMH (1998).

Roitt, I.V., Brostoff, J., Male, D.K. (1995): Kurzes Lehrbuch der Imunologie, 3. Auflage, Thieme, Stuttgart. New York: 87-106.

Safe, A.F., Warren, B., Corfield, A., McNulty, C.A., Watson, B., Mountford, R.A., Read, A. (1993): role of serology in monitoring treatment for Helicobacter pylori infection in elderly patients. Age ageing 22 (4): 256-259.

Sarosiek, J., Peura, D. E., Guerrant, R.L., Marshall, B.J. (1991): Mucolytic effects of H. pylori. Scand. J. gastroenterol.,. 26 Suppl. 187: 47-55

Schmitt, W., Haas, R. (1994): Genetic analysis of the H. pylori vacuolating cytotoxin: structural similarities with the IgA protease type of exported. Mol. Microbiol.12: 307-319.

Seifert, E. (1996): Helicobacter pylori und Magenkarzinom. In: Helicobacter pylori - Von der Grundlage zur Therapie. Malfertheiner, P. (Herausgeber). 2.Auflage. Georg Thieme Verlag. Stuttgart, New York: 109-120.

Sipponen, P., Varis, K., Fraki, O., Korri, U.M., Sepälä, K., Siurala, M. (1990): Cumulative 10 - year risk of symptomatic duodenal and gastric ulcer in patients with and without gastritis. A clinical follow - up of 454 patients. Scand. J. Gastroenterol. 25-960.

Sitas, F., Forman, D., Yarnell, J.W., Burr, M.L., Elwood, P.C., Pedley, S., Marks, K.J. (1991): Helicobacter pylori infection rates in relation to age and social class in a population of Welsh men. Gut 32: 25-28.

Slomiani, B.L., Nishikawa, H., Piotrowski, J., Okazaki, K., Slomiani, A. (1989): Lipolytic activity of Campylobacter pylori: effect of sofalcone. Gastroenterology. 94-399.

Sobala, G.M., Schorah, C.J., Shires, S., Lynch, D.A.F., Gallacher, B., Dixon, M.F., et al. (1993): Effect of eradication of Helicobacter pylori on gastric juice asorbic acid concen - Trations. Gut; 34: 1038.

Stadelmann, O. (1996): Helicobacter pylori und funktionelle Dyspepsie in: Helicobacter pylori - Von der Grundlage zur Therapie. Malfertheiner, P. 2. Auflage. Georg Thieme Verlag, Stutgart. New York: 75-76.

Stolte, M. und Heilmann, K. L. (1980): Neue Klassifikation und Graduierung der Gastritis. Leber-Magen-Darm. 19: 220-226.

Stolte, M., Bethge, B., Ritter, M., Lauer, F., Eidt, H. (1990): Praxis der Gastritis-Klassifikation. Endoskopie Heute 4. 228.230.

Stolte, M. (1994): Pathologie der Helicobacter pylori Krankheiten. In: Malfertheiner, P., editor. Helicobacter pylori - Von der Grundlage zur Therapie. Stuttgart. Thieme. 19.

Strickland, R.G., Mackay, I.R. (1973): A reappraisal of the natur and significance of chronic atrophic gastritis. Am. J. Dis. 18: 426-440.

Suerbaum, S. (1996): Bakterielle Physiologie und Virulenzfaktoren in: Helicobacter pylori - Von der Grundlage zur Therapie. Herausgegeben von Peter Malfertheiner. 2. Auflage. Georg-Thieme-Verlag, Stuttgart. New York. S.11-23.

Tarkkanen, J., Kosunen, T.U., Saksela, E. (1993): Contact of lymphocytes with Helicobacter pylori augments natural killer cell activity and induces production of gamma interferon. Ifect. Immun. 61-3012.

Tebbe, B., Schulzke, J.-D., Radenhausen, M., Orfanos, C.E. (1999): Bedeutung von Helicobacter pylor bei Dermatosen. In: Deutsches Ärzteblatt 1999; 96. Heft 34-35: A-2143-2148.

Toermer, H.J., Wolf, G. (1997): Fortschritte der Medizin 115. Jg.-Originalien Nr.II-III. 15-18.

Tonella, L., Walsh, B.J., Sanchez, J.C., Ou, K., Wilkins, M.R., Tyler, M., Frutiger, S., Gooley, A.A., Pescaru, I., Appel, R.D., Yan, J.X., Bairoch, A., Hoogland, C., Morch, F.S., Hughes, G.J., Williams, K.L., Hochstrasser, D.F. (1998): ’98 Escherichia coli SWISS-2DPAGE database update. Elektrophoresis. 19: 1960-71.

Twedt, D.C., Tams, T.R. (1989): Diseases of the stomach. In Sherding RG (ed): The cat: Diseases and clinical management; Vol.2; Churchill Liwingstone New York: 929-54.

Twedt, D.C., Magne, M.L. (1986): Chronic gastritis. In: Kirk RW (ed): Current Veterinary therapy 9. WB Saunders Philadelphia: 852-868.

Tytgat, G.N. (1994): Long - term consequences of Helicobacter pylori eradication. Scand J. Gastroenterol. 29 (suppl.): 38-44.

Van Bohemen, C. G., Langenberg, W. L., Rauws, E. A. J., Oudbier, J., Weterings, E. und Zanen, H. C. (1989): Rapidly decreased serum IgG to C. pylori following elimination of Campylobacter in histological chronic biopsy Campylobacter positive gastritis. Immunol. Letters. 20: 59-62.

Wallace, N., Beck, P.l., Moris G.P. Is there a role for leukotriens as mediators of ethanol-induced gastric mucosal damage ? Am. J. Physiol . 254-G117.

Watanabe, T., Tada, M., Nagai, H., Sasaki, S., Nakao, M. (1998): Helicobacter pylori infection induces gastric cancer in Mongolian gerbils. Gastroenterol.; 114: 642-648.

Whitaker, C.J., Dubiel, A.J., Galpin, O.P. (1993): Social and geographical risk factors in Helicobacter pylori infection. Epidemiol.Infect. 111: 63-70.

Widmer, M., de Korwin, J.D., Aucher, P., Thiberge, J.M., Suerbaum, S., Labigne, A., Fauchere, J.L. (1999): Performance of native and recombinant antigens for diagnosis of Helicobacter pylori infection. Eur J Clin Microbiol Infect Dis 18: 823-826.

Wotherspoon, A.C., C. Doglioni et al. (1993): Regression of primary low-grade B-cell lymphoma of mucosa associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 342, 575-7.

Yazawa, N., Fujimoto, M., Kikuchi, K., Kubo, M., Ihn, H., Sato, S., Tamaki, K. (1998): High seroprevalence of Helicobacter pylori infection in patients with systemic sclerosis: Association with esophageal involvement. J. Rheumatol.; 25: 650-653.

Zevering, Y., Jacob, L., Meyer, T.F. (1999): naturally acquired human immune responses against Helicobacter pylori and implications for vaccine development. Gut 45 . 465-474.


© Die inhaltliche Zusammenstellung und Aufmachung dieser Publikation sowie die elektronische Verarbeitung sind urheberrechtlich geschützt. Jede Verwertung, die nicht ausdrücklich vom Urheberrechtsgesetz zugelassen ist, bedarf der vorherigen Zustimmung. Das gilt insbesondere für die Vervielfältigung, die Bearbeitung und Einspeicherung und Verarbeitung in elektronische Systeme.
DiML DTD Version 4.0Zertifizierter Dokumentenserver
der Humboldt-Universität zu Berlin
HTML-Version erstellt am:
12.09.2006